rs12404427

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_206933.4(USH2A):​c.7506G>A​(p.Pro2502Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0827 in 1,613,400 control chromosomes in the GnomAD database, including 6,079 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.075 ( 470 hom., cov: 33)
Exomes 𝑓: 0.083 ( 5609 hom. )

Consequence

USH2A
NM_206933.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -2.03

Publications

9 publications found
Variant links:
Genes affected
USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
USH2A Gene-Disease associations (from GenCC):
  • Usher syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa 39
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 1-215900163-C-T is Benign according to our data. Variant chr1-215900163-C-T is described in ClinVar as Benign. ClinVar VariationId is 48584.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.03 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0816 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USH2ANM_206933.4 linkc.7506G>A p.Pro2502Pro synonymous_variant Exon 40 of 72 ENST00000307340.8 NP_996816.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USH2AENST00000307340.8 linkc.7506G>A p.Pro2502Pro synonymous_variant Exon 40 of 72 1 NM_206933.4 ENSP00000305941.3
USH2AENST00000674083.1 linkc.7506G>A p.Pro2502Pro synonymous_variant Exon 40 of 73 ENSP00000501296.1
ENSG00000229242ENST00000414995.1 linkn.61-562C>T intron_variant Intron 1 of 1 3

Frequencies

GnomAD3 genomes
AF:
0.0755
AC:
11471
AN:
151954
Hom.:
470
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0816
Gnomad AMI
AF:
0.0615
Gnomad AMR
AF:
0.0843
Gnomad ASJ
AF:
0.0406
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.0537
Gnomad FIN
AF:
0.0502
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0835
Gnomad OTH
AF:
0.0632
GnomAD2 exomes
AF:
0.0684
AC:
17142
AN:
250672
AF XY:
0.0676
show subpopulations
Gnomad AFR exome
AF:
0.0835
Gnomad AMR exome
AF:
0.0956
Gnomad ASJ exome
AF:
0.0411
Gnomad EAS exome
AF:
0.000218
Gnomad FIN exome
AF:
0.0519
Gnomad NFE exome
AF:
0.0782
Gnomad OTH exome
AF:
0.0590
GnomAD4 exome
AF:
0.0835
AC:
121987
AN:
1461328
Hom.:
5609
Cov.:
32
AF XY:
0.0823
AC XY:
59840
AN XY:
726974
show subpopulations
African (AFR)
AF:
0.0809
AC:
2707
AN:
33446
American (AMR)
AF:
0.0916
AC:
4095
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.0393
AC:
1027
AN:
26112
East Asian (EAS)
AF:
0.000731
AC:
29
AN:
39676
South Asian (SAS)
AF:
0.0582
AC:
5022
AN:
86258
European-Finnish (FIN)
AF:
0.0521
AC:
2782
AN:
53378
Middle Eastern (MID)
AF:
0.0331
AC:
191
AN:
5766
European-Non Finnish (NFE)
AF:
0.0915
AC:
101667
AN:
1111652
Other (OTH)
AF:
0.0740
AC:
4467
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
5933
11866
17799
23732
29665
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3810
7620
11430
15240
19050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0755
AC:
11478
AN:
152072
Hom.:
470
Cov.:
33
AF XY:
0.0736
AC XY:
5473
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.0816
AC:
3387
AN:
41484
American (AMR)
AF:
0.0843
AC:
1286
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.0406
AC:
141
AN:
3472
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5170
South Asian (SAS)
AF:
0.0537
AC:
259
AN:
4822
European-Finnish (FIN)
AF:
0.0502
AC:
530
AN:
10564
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0835
AC:
5674
AN:
67982
Other (OTH)
AF:
0.0621
AC:
131
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
538
1077
1615
2154
2692
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
134
268
402
536
670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0771
Hom.:
872
Bravo
AF:
0.0760
Asia WGS
AF:
0.0310
AC:
107
AN:
3478
EpiCase
AF:
0.0751
EpiControl
AF:
0.0759

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Apr 05, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 19, 2008
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 07, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Usher syndrome type 2A Benign:2
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
1.8
DANN
Benign
0.81
PhyloP100
-2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12404427; hg19: chr1-216073505; COSMIC: COSV56327776; API